Irreversible Electroporation (IRE): An Innovative Non‑Thermal Technology for Tumor Ablation
Irreversible Electroporation (IRE): An Innovative Non‑Thermal Technology for Tumor Ablation Irreversible electroporation (IRE) is a novel, non‑thermal tumor ablation technique that employs short, high‑voltage electrical pulses to induce permanent nanopores in the cell membrane, ultimately triggering cell death. Unlike thermal ablation methods (e.g., radiofrequency or microwave), which can cause collateral thermal necrosis of surrounding structures, […]
Magnetoporation: Cell Membrane Permeabilization by Magnetism
Effective delivery of therapeutic molecules like medications, genes, and proteins into cells is made possible by the novel biophysical technique known as magnetoporation, or magnetofection, which uses magnetic fields and nanoparticles to permeabilize cell membranes temporarily. This technique has become a viable substitute for conventional delivery methods because of its great accuracy, decreased cellular damage, […]
Successful Treatment of Perianal Squamous Cell Carcinoma Using Electrochemotherapy
Successful Treatment of Perianal Squamous Cell Carcinoma Using Electrochemotherapy Cancer remains one of the most formidable health challenges of our time, affecting millions worldwide. Recent advances in medical technology have introduced innovative treatments like electrochemotherapy, made possible through advanced devices such as those manufactured by Pars Tarava. This article examines the application of Pars Tarava’s […]
Successful Treatment of Elbow Tumor Using Electrochemotherapy: A Case Study
Successful Treatment of Elbow Tumor Using Electrochemotherapy: A Case Study Medical professionals often face significant challenges when treating complex and rare conditions. Among these, bone and soft tissue tumors present particular difficulties, sometimes leaving amputation as the only viable option. This report details the case of a 27-year-old female patient with a persistent right elbow […]
International patent registration of the real-time tissue impedance measurement–based cancer treatment system by Persian Tarava
International patent registration of the real-time tissue impedance measurement–based cancer treatment system by Persian Tarava Since its founding, Persian Tarava has led Iran’s efforts to localize cutting-edge cancer therapies by becoming the country’s first and only manufacturer of electroporation devices. Backed by R&D expertise dating to 2006, our team has successfully treated superficial, deep, even […]
Electrochemotherapy: A Case Study on Gastrointestinal Cancer and Modern Treatment Breakthroughs
Electrochemotherapy: A Case Study on Cancer and Modern Treatment Breakthroughs Cancer is still one of the most urgent worldwide health issues, Affecting millions every year. Among its many varieties, gastrointestinal cancers provide particular challenges because of their complexity and broad influence, usually calling for creative and efficient treatment strategies. Pars Tarava, Iran’s first producer of electrochemotherapy […]
Successful Treatment of Ovarian Cancer Metastasis Using Electrochemotherapy with the Pars Tarava Device
Successful Treatment of Ovarian Cancer Metastasis Using Electrochemotherapy with the Pars Tarava Device Cancer continues to challenge global health systems, particularly in cases where conventional therapies fall short. New, targeted treatments are becoming increasingly necessary for advanced or inoperable tumors. One such promising approach is electrochemotherapy (ECT), a technique that combines chemotherapy with short, intense […]
Treatment of Canine Transmissible Venereal Tumor with Electrochemotherapy
Treatment of Canine Transmissible Venereal Tumor with Electrochemotherapy Canine Transmissible Venereal Tumor (CTVT) is a unique and contagious cancer affecting dogs worldwide. Unlike typical cancers that arise from the host’s own cells, CTVT is transmissible – the living cancer cells themselves spread between animals. Transmission occurs most commonly during mating, when tumor cells are physically […]
